![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 01, 2017 11:02:41 AM
Nothing has changed fundementaly and in fact with every day that passes we become fundementaly stronger then the previous week.
REVENUE IS CLOSER THEN EVER TO STARTING!
MORE ANNOUNCEMENTS ON NEW PRE CLINICAL TRIALS FOR THERE CREAM WILL BE ANNOUNCED IN AS EARLY AS 45 days!
SUBLINGUAL TABLET REVENUE TO START LATER THIS YEAR!
AND THE ONE I LIKE IS OUR MULTIPLE MYELOMA STUDY THAT IS SET UP FOR ORPHAN DRUG!
Patients will pay here and is why I remain long on this stock.
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM